Tag: GCP compliance

Escalation Paths and Decision Rights for GCP-Critical Issues

Posted on By digi

Escalation Paths and Decision Rights for GCP-Critical Issues Escalation Paths and Decision Rights for GCP-Critical Issues 1. Introduction to GCP Compliance and Its Importance Good Clinical Practice (GCP) guidelines are essential in compliance with international ethical and scientific quality standards in clinical research. GCP ensures the protection of human subjects and the credibility of clinical…

Read More “Escalation Paths and Decision Rights for GCP-Critical Issues” »

Sponsor & CRO GCP Obligations

Quantitative vs Qualitative Approaches to Ranking Clinical Risks

Posted on By digi

Quantitative vs Qualitative Approaches to Ranking Clinical Risks In the context of clinical trials, particularly within the realms of electronic data capture in clinical trials and regulatory compliance, understanding how to evaluate and rank clinical risks is paramount. This guide provides a structured approach to navigating the quantitative and qualitative methodologies for assessing risks associated…

Read More “Quantitative vs Qualitative Approaches to Ranking Clinical Risks” »

Risk Assessment & Risk Controls

Monitoring Source Documentation Quality: Checklists and Metrics

Posted on By digi

Monitoring Source Documentation Quality: Checklists and Metrics The quality of source documentation in clinical trials is paramount for ensuring the reliability of trial results and adhering to regulatory compliance. In this tutorial, we will provide a comprehensive step-by-step guide on how to effectively monitor the quality of source documentation using checklists and metrics. This is…

Read More “Monitoring Source Documentation Quality: Checklists and Metrics” »

Visit Management & Source Documentation

Training Site Staff on Source Standards, Legibility and Corrections

Posted on By digi

Training Site Staff on Source Standards, Legibility and Corrections Training Site Staff on Source Standards, Legibility and Corrections Clinical trials play a critical role in the development of new treatments and therapies. Ensuring that site staff are adequately trained on source standards, legibility, and corrections is paramount for maintaining the integrity of the clinical trial…

Read More “Training Site Staff on Source Standards, Legibility and Corrections” »

Visit Management & Source Documentation

Global Program Governance: Study SteerCos, QMS and Quality Councils

Posted on By digi

Global Program Governance: Study SteerCos, QMS and Quality Councils Global Program Governance: Study SteerCos, QMS and Quality Councils In the rapidly evolving landscape of clinical research, effective governance structure is essential for successful outcomes. Organizations engaged in the conduct of clinical trials must navigate complex regulatory environments across multiple jurisdictions while maintaining high standards of…

Read More “Global Program Governance: Study SteerCos, QMS and Quality Councils” »

Sponsor & CRO GCP Obligations

Inspection Readiness for Sponsors and CROs Across Portfolios

Posted on By digi

Inspection Readiness for Sponsors and CROs Across Portfolios Inspection Readiness for Sponsors and CROs Across Portfolios Introduction to Inspection Readiness In the realm of clinical research, particularly in edge clinical trials, maintaining an optimal level of inspection readiness is paramount for sponsors and Contract Research Organizations (CROs). Inspection readiness entails ensuring that all processes, documentation,…

Read More “Inspection Readiness for Sponsors and CROs Across Portfolios” »

Sponsor & CRO GCP Obligations

Linking Risk Assessments to Monitoring, QA and Vendor Oversight Plans

Posted on By digi

Linking Risk Assessments to Monitoring, QA and Vendor Oversight Plans Linking Risk Assessments to Monitoring, QA and Vendor Oversight Plans Understanding the Importance of Risk Assessments in Clinical Trials Risk assessments are a cornerstone of clinical trial management, particularly in the framework of Good Clinical Practice (GCP). With the increased complexity of clinical trials, particularly…

Read More “Linking Risk Assessments to Monitoring, QA and Vendor Oversight Plans” »

Risk Assessment & Risk Controls

Real-Time Data Entry and Source Documentation During Study Visits

Posted on By digi

Real-Time Data Entry and Source Documentation During Study Visits Real-Time Data Entry and Source Documentation During Study Visits The successful execution of clinical trials hinges on accurate data collection and thorough source documentation. This guide is designed for clinical operations, regulatory affairs, and medical affairs professionals engaged in clinical research, particularly in the context of…

Read More “Real-Time Data Entry and Source Documentation During Study Visits” »

Visit Management & Source Documentation

Capturing Unscheduled Visits, Concomitant Medications and Adverse Events

Posted on By digi

Capturing Unscheduled Visits, Concomitant Medications and Adverse Events Capturing Unscheduled Visits, Concomitant Medications and Adverse Events Clinical research professionals are tasked with ensuring that the clinical trial process is managed consistently and comprehensively. One significant aspect of clinical trials in the ICH-GCP regulated environment is the documentation of unscheduled visits, concomitant medications, and adverse events…

Read More “Capturing Unscheduled Visits, Concomitant Medications and Adverse Events” »

Visit Management & Source Documentation

Auditing CROs and Vendors: Evidence Regulators Expect to See

Posted on By digi

Auditing CROs and Vendors: Evidence Regulators Expect to See Auditing CROs and Vendors: Evidence Regulators Expect to See In the complex landscape of clinical research, effective oversight of Contract Research Organizations (CROs) and vendors is essential for ensuring compliance with Good Clinical Practice (GCP) regulations. This tutorial guide provides a comprehensive framework for auditing CROs…

Read More “Auditing CROs and Vendors: Evidence Regulators Expect to See” »

Sponsor & CRO GCP Obligations